{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:35:12Z","timestamp":1762868112523},"reference-count":39,"publisher":"Georg Thieme Verlag KG","issue":"07","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Endocrinol Diabetes"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Congenital Adrenal Hyperplasia is a group of genetic autosomal recessive disorders that affects adrenal steroidogenesis in the adrenal cortex. One of the most common defects associated with Congenital Adrenal Hyperplasia is the deficiency of 21-hydroxylase enzyme, responsible for the conversion of 17-hydroxyprogesterone to 11-deoxycortisol and progesterone to deoxycorticosterone. The impairment of cortisol and aldosterone production is directly related to the clinical form of the disease that ranges from classic or severe to non-classic or mild late onset. The deficiency of 21-hydroxylase enzyme results from pathogenic variants on CYP21A2 gene that, in the majority of the cases, compromise enzymatic activity and are strongly correlated with the clinical severity of the disease. Due to the exceptionally high homology and proximity between the gene and the pseudogene, more than 90% of pathogenic variants result from intergenic recombination. Around 75% are deleterious variants transferred from the pseudogene by gene conversion, during mitosis. About 20% are due to unequal crossing over during meiosis and lead to duplications or deletions on CYP21A2 gene. Molecular genetic analysis of CYP21A2 variants is of major importance for confirmation of clinical diagnosis, predicting prognosis and for an appropriate genetic counselling. In this review we will present an update on the genetic analysis of CYP21A2 gene variants in CAH patients performed in our department.<\/jats:p>","DOI":"10.1055\/a-1108-1419","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:13:38Z","timestamp":1583367218000},"page":"477-481","source":"Crossref","is-referenced-by-count":20,"title":["Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency: An Update on Genetic Analysis of CYP21A2 Gene"],"prefix":"10.1055","volume":"129","author":[{"given":"Berta","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Genetics, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal"},{"name":"i3S, Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto, Porto, Portugal"}]},{"given":"C. Joana","family":"Marques","sequence":"additional","affiliation":[{"name":"Genetics, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal"},{"name":"i3S, Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto, Porto, Portugal"}]},{"given":"Rita","family":"Santos-Silva","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Centro Hospitalar Universit\u00e1rio S. Jo\u00e3o, Porto, Portugal"}]},{"given":"Manuel","family":"Fontoura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Centro Hospitalar Universit\u00e1rio S. Jo\u00e3o, Porto, Portugal"}]},{"given":"Davide","family":"Carvalho","sequence":"additional","affiliation":[{"name":"i3S, Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto, Porto, Portugal"},{"name":"Department of Endocrinology, Diabetes e Metabolism, Centro Hospitalar Universit\u00e1rio S. Jo\u00e3o, Faculty of Medicine, Porto, Portugal"}]},{"given":"Filipa","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Genetics, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal"},{"name":"i3S, Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto, Porto, Portugal"}]}],"member":"194","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society Clinical Practice Guideline","volume":"103","author":"P W Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/EJE-18-0279","article-title":"Rare defects in adrenal steroidogenesis","volume":"179","author":"W L Miller","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"ref3","first-page":"866","article-title":"Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"81","author":"S Y Pang","year":"1988","journal-title":"Pediatrics"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/gim.2017.46","article-title":"Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians","volume":"19","author":"F Hannah-Shmouni","year":"2017","journal-title":"Genet Med"},{"key":"ref5","first-page":"650","article-title":"High frequency of nonclassical steroid 21-hydroxylase deficiency","volume":"37","author":"P W Speiser","year":"1985","journal-title":"Am J Hum Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jcem-57-2-320","article-title":"Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data","volume":"57","author":"M I New","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/jc.2004-1728","article-title":"Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population","volume":"90","author":"S M Baumgartner-Parzer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","first-page":"650","article-title":"High frequency of nonclassical steroid 21-hydroxylase deficiency","volume":"37","author":"P W Speiser","year":"1985","journal-title":"Am J Hum Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ando.2007.06.019","article-title":"Hormonal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"68","author":"A Bachelot","year":"2007","journal-title":"Ann Endocrinol (Paris)"},{"key":"ref10","first-page":"1993","volume-title":"21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia","author":"S Nimkarn","year":"2002"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/EJE-16-0171","article-title":"Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction","volume":"175","author":"D F de Carvalho","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1210\/jc.2006-1645","article-title":"Extensive clinical experience: Nonclassical 21-hydroxylase deficiency","volume":"91","author":"M I New","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1517\/14656560802559932","article-title":"Polycystic ovary syndrome: treatment strategies and management","volume":"9","author":"H F Escobar-Morreale","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/09513590801911992","article-title":"Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women","volume":"24","author":"M Fanta","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0889-8529(05)70285-1","article-title":"Congenital adrenal hyperplasia","volume":"26","author":"S Pang","year":"1997","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jsbmb.2016.06.015","article-title":"Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia","volume":"165","author":"A A Parsa","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1507\/endocrj.K07-119","article-title":"A male case of nonclassical 21-hydroxylase deficiency first manifested in his sixties with adrenocortical incidentaloma","volume":"55","author":"T Nigawara","year":"2008","journal-title":"Endocr J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"M Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"ref19","first-page":"17","article-title":"Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450(C21) gene: Implications for steroid 21-hydroxylase deficiency","volume":"1","author":"Y Higashi","year":"1988","journal-title":"Am J Hum Genet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0888-7543(89)90002-5","article-title":"Two distinct areas of unequal crossingover within the steroid 21-hydroxylase genes produce absence of CYP21B","volume":"5","author":"P A Donohoue","year":"1989","journal-title":"Genomics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2009-0487","article-title":"Duplications of the functional CYP21A2 gene are primarily restricted to Q318X alleles: Evidence for a founder effect","volume":"94","author":"S Kleinle","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e2138","DOI":"10.1371\/journal.pone.0002138","article-title":"High frequency of copy number variations and sequence variants at CYP21A2 locus: Implication for the genetic diagnosis of 21-hydroxylase deficiency","volume":"14","author":"S Parajes","year":"2008","journal-title":"PLoS One"},{"key":"ref23","first-page":"298","volume":"35","author":"S Menab\u00f2","year":"2012","journal-title":"Endocrinol Invest"},{"key":"ref24","first-page":"245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","author":"P C White","year":"2000","journal-title":"Endocr Rev"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJMra021561","article-title":"Congenital adrenal hyperplasia","volume":"21","author":"P W Speiser","year":"2003","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1055\/s-0029-1237363","article-title":"Mutational characterization of steroid 21-hydroxylase gene in Portuguese patients with congenital adrenal hyperplasia","volume":"118","author":"C J Marques","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2265.2006.02465.x","article-title":"High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect","volume":"64","author":"L Loidi","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-0032-1323805","article-title":"Comprehensive genetic analysis and structural characterization of CYP21A2 mutations in CAH patients","volume":"120","author":"B Carvalho","year":"2012","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1093\/nar\/gnf056","article-title":"Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification","volume":"15","author":"J P Schouten","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cca.2009.01.008","article-title":"Multiplex ligation-dependent probe amplification (MLPA) assay for the detection of CYP21A2 gene deletions\/duplications in congenital adrenal hyperplasia: First technical report","volume":"402","author":"P Concolino","year":"2009","journal-title":"Clin Chim Acta"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/clinchem\/48.6.818","article-title":"Multiplex minisequencing of the 21-hydroxylase gene as a rapid strategy to confirm congenital adrenal hyperplasia","volume":"48","author":"N Krone","year":"2002","journal-title":"Clin Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/pd.1584","article-title":"Gene duplications in 21-hydroxylase deficiency: The importance of accurate molecular diagnosis in carrier detection and prenatal diagnosis","volume":"26","author":"B Ezquieta","year":"2006","journal-title":"Prenat Diagn"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/humu.22981","article-title":"HGVS Recommendations for the description of sequence variants. update","volume":"37","author":"J T den Dunnen","year":"2016","journal-title":"Hum Mutat"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/0300060516685204","article-title":"Molecular diagnosis of Chinese patients with 21-hydroxylase deficiency and analysis of genotype-phenotype correlations","volume":"45","author":"B Zhang","year":"2017","journal-title":"J Int Med Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1210\/jcem.85.3.6441","article-title":"Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany","volume":"85","author":"N Krone","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000497485","article-title":"CYP21A2 gene pathogenic variants: a multicenter study on genotype-phenotype correlation from a Portuguese pediatric cohort","volume":"91","author":"R Santos Silva","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1073\/pnas.1300057110","article-title":"Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency","volume":"110","author":"M I New","year":"2013","journal-title":"PNAS"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.fertnstert.2018.11.007","article-title":"Genetics of congenital adrenal hyperplasia and genotype-phenotype correlation","volume":"111","author":"M L Narasimhan","year":"2019","journal-title":"Fertil Steril"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jsbmb.2016.06.015","article-title":"Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia","volume":"165","author":"A A Parsa","year":"2017","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Experimental and Clinical Endocrinology &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1108-1419.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:31:16Z","timestamp":1626741076000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1108-1419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":39,"journal-issue":{"issue":"07","published-online":{"date-parts":[[2021,7,19]]},"published-print":{"date-parts":[[2021,7]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1108-1419","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0947-7349","1439-3646"],"issn-type":[{"value":"0947-7349","type":"print"},{"value":"1439-3646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]}}}